ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
CalciMedica Inc

CalciMedica Inc (CALC)

5.20
0.04
(0.78%)
Closed May 27 4:00PM
5.20
0.00
(0.00%)
After Hours: 5:16PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
5.20
Bid
4.94
Ask
5.68
Volume
23,865
5.02 Day's Range 5.2917
1.75 52 Week Range 8.59
Market Cap
Previous Close
5.16
Open
5.15
Last Trade
1359
@
5.2
Last Trade Time
Financial Volume
$ 124,172
VWAP
5.2031
Average Volume (3m)
21,074
Shares Outstanding
5,684,873
Dividend Yield
-
PE Ratio
-0.91
Earnings Per Share (EPS)
-6.04
Revenue
-
Net Profit
-34.36M

About CalciMedica Inc

CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune... CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases. CRAC channels serve to replenish calcium levels in the endoplasmic reticulum (ER) and provide calcium for cellular signaling events. Its lead product candidate, Auxora, is an intravenous-formulated, small molecule CRAC channel inhibitor. Auxora has the capability to modulate the immune response and protect against tissue cell injury, addressing inflammatory diseases, such as acute pancreatitis (AP), asparaginase-associated acute pancreatitis (AAP), acute kidney injury (AKI), and acute hypoxemic respiratory failure. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
CalciMedica Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CALC. The last closing price for CalciMedica was $5.16. Over the last year, CalciMedica shares have traded in a share price range of $ 1.75 to $ 8.59.

CalciMedica currently has 5,684,873 shares outstanding. The market capitalization of CalciMedica is $31.27 million. CalciMedica has a price to earnings ratio (PE ratio) of -0.91.

CALC Latest News

CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates PR Newswire LA JOLLA, Calif., May 13, 2024 Last patient enrolled in CARPO, Phase 2b trial of...

CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024

CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024 PR Newswire LA JOLLA, Calif., May 7, 2024 Collaborators from Cedars-Sinai to present human proteomics data supporting...

CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis

CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis PR Newswire LA JOLLA, Calif., April 24, 2024 Full target enrollment of 216 patients...

CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates PR Newswire LA JOLLA, Calif., March 28, 2024 Enrollment in CARPO, Phase 2b trial of Auxora™ in acute...

CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference

CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference PR Newswire LA JOLLA, Calif., March 13, 2024 Therapeutic...

CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference

CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference PR Newswire LA JOLLA, Calif., Feb. 28...

CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for the Treatment of Severe Acute Kidney Injury

CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for the Treatment of Severe Acute Kidney Injury PR Newswire LA JOLLA, Calif., Feb. 13, 2024 Phase 2 trial...

CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference PR Newswire LA JOLLA, Calif., Feb. 7, 2024 LA JOLLA, Calif., Feb. 7, 2024 /PRNewswire/ -- CalciMedica...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.31-5.626134301275.515.95.02189175.36697404CS
4-0.3-5.454545454555.56.2654.52146905.54182004CS
120.6714.79028697574.536.2653.3101210744.62431198CS
262.0163.00940438873.198.382.68176174.7610689CS
520.510.63829787234.78.591.75183834.03125938CS
156-0.07-1.328273244785.278.591.75191884.1517412CS
260-0.07-1.328273244785.278.591.75191884.1517412CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LUCYInnovative Eyewear Inc
$ 0.983
(428.49%)
944.4M
AKANAkanda Corporation
$ 4.07
(70.29%)
39.11M
TKLFYoshitsu Company Ltd
$ 0.3496
(53.33%)
84.5M
ONMDOneMedNet Corporation
$ 2.251
(53.13%)
136.04M
MRUSMerus NV
$ 59.92
(35.97%)
6.91M
VSTMVerastem Inc
$ 4.0901
(-66.42%)
19.68M
TOIIWOncology Institute Inc
$ 0.0443
(-55.61%)
280.55k
SNSESensei Biotherapeutics Inc
$ 0.7912
(-45.43%)
1.41M
GNLXGenelux Corporation
$ 2.61
(-43.26%)
3.32M
AUVIApplied UV Inc
$ 0.32
(-33.33%)
5.18M
LUCYInnovative Eyewear Inc
$ 0.983
(428.49%)
944.4M
GWAVGreenwave Technology Solutions Inc
$ 0.0843
(-4.85%)
428.98M
NCPLNetcapital Inc
$ 0.20
(14.42%)
191.35M
HLTHCue Health Inc
$ 0.0931
(-1.27%)
160.21M
ONMDOneMedNet Corporation
$ 2.251
(53.13%)
136.04M

Your Recent History

Delayed Upgrade Clock